申请人:Sumitomo Chemical Company, Limited
公开号:US04099002A1
公开(公告)日:1978-07-04
3,4-Dihydro-2(1H)-quinazolinone derivatives of the formula, ##STR1## wherein R.sub.1 and R.sub.2 signify individually a hydrogen atom, a lower alkyl group, a lower alkoxy group, a nitro group, a trifluoromethyl group, a lower alkylthio group, a lower alkylsulfonyl group or a halogen atom; R.sub.3 signifies a phenyl group, a halophenyl group, a lower alkylphenyl group, a lower alkoxyphenyl group, a trifluoromethylphenyl group, a lower cycloalkyl group, a lower cycloalkenyl group, a pyridyl group, a pyrrolyl group, a furyl group, a thienyl group or a naphthyl group; R.sub.4 signifies a lower alkyl group, a lower alkenyl group, an aralkyl group, a lower cycloalkylalkyl group, a lower cycloalkyl group, a lower alkoxyalkyl group, a lower alkylthioalkyl group, a lower hydroxyalkyl group, a lower alkanoyloxyalkyl group, a phenyl group, a halophenyl group, a trifluoromethylphenyl group, a lower alkylphenyl group a lower alkoxyphenyl group, a pyridyl group or a group of the formula ##STR2## wherein n signifies an integer of 1 to 4; and R.sub.5 and R.sub.6 signify individually a lower alkyl group, provided that they may form together with the adjacent nitorgen atom an optionally substituted 5- or 6-membered heterocyclic ring, which may further contain a hetero atom); and R signifies a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower alkoxyalkyl group, a lower alkylthioalkyl group, an aralkyl group, a lower cycloalkylalkyl group, a lower trihalomethylalkyl group or a group of the formula ##STR3## (wherein n, R.sub.5 and R.sub.6 signify the same as defined above), which have excellent pharmacological properties such as central nervous system depressant, anti-inflammatory, analgestic and anti-microbial activities, can be produced by reducing a compound of the formula, ##STR4## wherein R, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 have the same meanings as defined above; and X.sub.1, X.sub.2 and X.sub.3 signify individually a halogen atom, or by the substitution reaction of the ring nitrogen atom of a 1 or 3-unsubstituted 3,4-dihydro-2(1H)-quinazolinone derivative.
3,4-二氢-2(1H)-喹唑啉酮衍生物的化学式如下:其中R.sub.1和R.sub.2分别表示氢原子、低烷基基团、低烷氧基团、硝基团、三氟甲基基团、低烷硫基团、低烷基磺酰基团或卤素原子;R.sub.3表示苯基、卤代苯基、低烷基苯基、低烷氧基苯基、三氟甲基苯基、低环烷基、低环烯基、吡啶基、吡咯基、呋喃基、噻吩基或萘基;R.sub.4表示低烷基基团、低烯基基团、芳基烷基、低环烷基烷基、低环烷基、低烷氧基烷基、低烷硫基烷基、低羟基烷基、低酰氧基烷基、苯基、卤代苯基、三氟甲基苯基、低烷基苯基、低烷氧基苯基、吡啶基或化学式##STR2##中的基团;其中n表示1至4的整数;R.sub.5和R.sub.6分别表示低烷基基团,但它们可以与相邻的氮原子一起形成一个可选择取代的5-或6-成员杂环环,该环可能进一步包含一个杂原子);R表示氢原子、低烷基基团、低烯基基团、低烷氧基烷基、低烷硫基烷基、芳基烷基、低环烷基烷基、低三卤甲基烷基或化学式##STR3##中的基团(其中n、R.sub.5和R.sub.6的定义与上述相同),这些化合物具有出色的药理特性,如中枢神经系统抑制剂、抗炎、镇痛和抗微生物活性,可以通过还原化合物的方法得到,该化合物的化学式如下:其中R、R.sub.1、R.sub.2、R.sub.3和R.sub.4的含义与上述相同;X.sub.1、X.sub.2和X.sub.3分别表示卤素原子,或通过对1或3-未取代的3,4-二氢-2(1H)-喹唑啉酮衍生物进行环氮原子的取代反应得到。